EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in Prostate Cancer Biomarkers and Probes

Keyi Li, Qiao Wang, Xiaoying Tang, Ozioma Udochukwu Akakuru, Ruobing Li, Yan Wang, Renran Zhang, Zhenqi Jiang iD, Zhuo Yang

Cyborg and Bionic Systems · 2024-01 · 5

DOI: 10.34133/cbsystems.0129 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cyborg and Bionic Systems, online erschienen am 27.06.2024. Verfasst von Keyi Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscope, General Hospital of Northern Theater Command, Shenyang, Liaoning, P. R. China. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is one of the most prevalent malignant tumors in men worldwide, and early diagnosis is essential to improve patient survival. This review provides a comprehensive discussion of recent advances in prostate cancer biomarkers, including molecular, cellular, and exosomal biomarkers. The potential of various biomarkers such as gene fusions (TMPRSS2-ERG), noncoding RNAs (SNHG12), proteins (PSA, PSMA, AR), and circulating tumor cells (CTCs) in the diagnosis, prognosis, and targeted therapies of prostate cancer is emphasized. In addition, this review systematically explores how multi-omics data and artificial intelligence technologies can be used for biomarker discovery and personalized medicine applications. In addition, this review provides insights into the development of specific probes, including fluorescent, electrochemical, and radionuclide probes, for sensitive and accurate detection of prostate cancer biomarkers. In conclusion, this review provides a comprehensive overview of the status and future directions of prostate cancer biomarker research, emphasizing the potential for precision diagnosis and targeted therapy.

Autor:innen und Institutionen

  • Department of Endoscope, General Hospital of Northern Theater Command, Shenyang, Liaoning, P. R. China.
  • School of Medical Technology, Beijing Institute of Technology, Beijing, P. R. China.
  • Department of Chemical and Petroleum Engineering, Schulich School of Engineering, University of Calgary, Alberta T2N 1N4, Canada.

ORCID-Profile: Zhenqi Jiang

Zitieren

APA

Li, K., Wang, Q., Tang, X., Akakuru, O. U., Li, R., Wang, Y., Zhang, R., Jiang, Z., & Yang, Z. (2024). Advances in Prostate Cancer Biomarkers and Probes. Cyborg and Bionic Systems, 5. https://doi.org/10.34133/cbsystems.0129

Vancouver

Li K, Wang Q, Tang X, Akakuru OU, Li R, Wang Y, et al. Advances in Prostate Cancer Biomarkers and Probes. Cyborg and Bionic Systems. 2024;5. doi:10.34133/cbsystems.0129

BibTeX
@article{Li2024,
  author = {Li, Keyi and Wang, Qiao and Tang, Xiaoying and Akakuru, Ozioma Udochukwu and Li, Ruobing and Wang, Yan and Zhang, Renran and Jiang, Zhenqi and Yang, Zhuo},
  title = {Advances in Prostate Cancer Biomarkers and Probes},
  journal = {Cyborg and Bionic Systems},
  year = {2024},
  volume = {5},
  doi = {10.34133/cbsystems.0129}
}
Kostenlos starten →